Middle East & Africa Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies) and Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others)
Market Introduction
Middle East & Africa region consists of Saudi Arabia, South Africa, UAE and rest of MEA. Saudi Arabia is the largest market for blood brain barrier technologies market. Saudi Arabia's blood brain barrier technologies market is anticipated to witness a strong upsurge in the revenues during the forecast period on the back of growing healthcare awareness, rising neurodegenerative disorders. Greater awareness of health issues and increasing consumption of healthcare services sustain a substantial market for various therapies and treatments. Government of Saudi Arabia is working towards the betterment of population of the country. The improvement in the healthcare services, have increased in the last few years is from 5.9% of the government’s total budget in 2006 to 7.0% in 2014. In Saudi Arabia, increasing demand for healthcare and government initiatives favoring an increased participation from the private sector for the expansion in private sector and investors .
Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. The COVID-19 pandemic has become the most significant challenge in the region. This challenge will be especially frightening for the region’s fragile and conflict-torn states—such as Iraq (1,963,264), Sudan (38,000), Iran (5,378,408), Israel (1,202,212) and Yemen (8,527) as it will lead to reduce imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The blood brain barrier technologies market in this pandemic is on rising, due to more of research about relation of blood brain barrier technologies with COVID-19 infection and its effect on the human body. Thus, pandemic has a positive impact on blood brain barrier technologies market.
Get more information on this report : 
Market Overview and Dynamics
The blood brain barrier technologies market in Middle East & Africa is expected to grow from US$ 196.72 million by 2028 from US$ 43.51 million in 2021. The market is estimated to grow at a CAGR of 24.1% from 2021 to 2028. Some neurologic disorders such as strokes, neuropathy, Alzheimer's disease, and Parkinson's disease are more common in the elderly, and their prevalence is increasing with higher life expectancies. According to the WHO, the population is aging rapidly worldwide. Between 2015 and 2050, the world's population over 60 years will nearly double, from 12% to 22%, and mental and neurological disorders among older adults are likely to account for 6.6% of the total disability-adjusted life year (DALYs) for this age group. Also, as per the same source, approximately 15% of adults aged 60 and over have a mental disorder. According to the CDC, Alzheimer's disease is the fifth leading cause of death in people 65 years and above. Also, the number of people living with Alzheimer's disease doubles every five years. Also the death rate due to neurological disorders is also increasing. For instance, according to the Alzheimer's Association, 1 in 3 seniors dies with Alzheimer's or dementia. Therefore, rising prevalence of age-associated neurological disorders increases the blood brain barrier technologies or better drug delivery. This factor is propelling the growth of the blood-brain barrier technologies market.
Key Market Segments
In terms of technology, the increasing permeability segment accounted for the largest share of the Middle East & Africa blood brain barrier technologies market in 2021. In terms of application, the parkinson’s disease segment accounted for the largest share of the Middle East & Africa blood brain barrier technologies market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the blood brain barrier technologies market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Bristol-Myers Squibb Company; Pfizer, Inc.; and Johnson & Johnson Services, Inc. among others.
Reasons to buy report
- To understand the Middle East & Africa blood brain barrier technologies market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East & Africa blood brain barrier technologies market
- Efficiently plan M&A and partnership deals in Middle East & Africa blood brain barrier technologies market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East & Africa blood brain barrier technologies market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East & Africa region.
Middle East & Africa Blood Brain Barrier Technologies Market Segmentation
Middle East & Africa Blood Brain Barrier Technologies Market – By Technology
- Bispecific Antibody RMT Approach
- Trojan Horse Approach
- Increasing Permeability
- Passive Diffusion
- Other Non-Invasive BBB Technologies
Middle East & Africa Blood Brain Barrier Technologies Market – By Application
- Alzheimer’s Disease
- Epilepsy
- Parkinson’s Disease
- Multiple Sclerosis
- Hunter’s Syndrome
- Brain Cancer
- Others
Middle East & Africa Blood Brain Barrier Technologies Market – By Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
Middle East & Africa Blood Brain Barrier Technologies Market – Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Blood Brain Barrier Technologies Market – By Technology
1.3.2 Middle East & Africa Blood Brain Barrier Technologies Market – By Application
1.3.3 Middle East & Africa Blood Brain Barrier Technologies Market– By Country
2. Middle East & Africa Blood Brain Barrier Technologies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Blood Brain Barrier Technologies Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Fostering Prevalence of Neurological Disorders
5.1.2 Scaling Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.2 Market Restraints
5.2.1 Hurdles in Brain Medication Delivery
5.3 Market Opportunities
5.3.1 Higher Number of Product Approvals and Launches
5.4 Future Trends
5.4.1 Elevating Demand Nanoparticles for Brain Drug Delivery
5.5 Impact Analysis
6. Middle East & Africa Blood Brain Barrier Technologies – Market Analysis
6.1 Middle East & Africa Blood Brain Barrier Technologies Market Revenue Forecast and Analysis
7. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Overview
7.2 Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
7.3 Bispecific Antibody RMT Approach
7.3.1 Overview
7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Trojan Horse Approach
7.4.1 Overview
7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Increasing Permeability
7.5.1 Overview
7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Passive Diffusion
7.6.1 Overview
7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Other Non-Invasive BBB Technologies
7.7.1 Overview
7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – By Application
8.1 Overview
8.2 Middle East & Africa Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parkinson’s Disease
8.5.1 Overview
8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
8.6.1 Overview
8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hunter’s Syndrome
8.7.1 Overview
8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Brain Cancer
8.8.1 Overview
8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Blood Brain Barrier Technologies Market – Country Analysis
9.1 Overview
9.1.1 Middle East & Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
9.1.1.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.1.3 Saudi Arabia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.2 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 South Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.2.3 South Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.3 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UAE: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.3.3 UAE: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.4 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.4.3 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East & Africa Blood Brain Barrier Technologies Market
10.1 Impact Assessment of COVID-19 Pandemic
11. Middle East & Africa Blood Brain Barrier Technologies Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eli Lilly and Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson and Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. South Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. South Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Organic Developments Done By Companies
Table 11. Inorganic Developments Done By Companies
Table 12. Glossary of Terms, Blood Brain Barrier Technologies Market
LIST OF FIGURES
Figure 1. Middle East & Africa Blood Brain Barrier Technologies Market Segmentation
Figure 2. Middle East & Africa Blood Brain Barrier Technologies Market Segmentation, By Country
Figure 3. Middle East & Africa Blood Brain Barrier Technologies Market Overview
Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market
Figure 5. The UAE to Show Significant Growth During Forecast Period
Figure 6. Middle East & Africa Blood Brain Barrier Technologies Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
Figure 10. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
Figure 16. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Middle East & Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
Figure 25. Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa blood brain barrier technologies market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution